Literature DB >> 20237901

Laminin-derived peptide AG73 regulates migration, invasion, and protease activity of human oral squamous cell carcinoma cells through syndecan-1 and beta1 integrin.

Adriane S Siqueira1, Letícia N Gama-de-Souza, Maria Vanda C Arnaud, João J V Pinheiro, Ruy G Jaeger.   

Abstract

Squamous cell carcinoma is a prevalent head and neck tumor with high mortality. We studied the role played by laminin alpha1 chain peptide AG73 on migration, invasion, and protease activity of cells (OSCC) from human oral squamous cell carcinoma. Immunohistochemistry and immunofluorescence analyzed expression of laminin alpha1 chain and MMP9 in oral squamous cells carcinoma in vivo and in vitro. Migratory activity of AG73-treated OSCC cells was investigated by monolayer wound assays and in chemotaxis chambers. AG73-induced invasion was assessed in Boyden chambers. Invasion depends on MMPs. Conditioned media from cells grown on AG73 was subjected to zymography. We searched for AG73 receptors related to these activities in OSCC cells. Immunofluorescence analyzed AG73-induced colocalization of syndecan-1 and beta1 integrin. Cells had these receptors silenced by siRNA, followed by treatment with AG73 and analysis of migration, invasion, and protease activity. Oral squamous cell carcinoma expresses laminin alpha1 chain and MMP9. OSCC cells treated with AG73 showed increased migration, invasion, and protease activity. AG73 induced colocalization of syndecan-1 and beta1 integrin. Knockdown of these receptors decreased AG73-dependent migration, invasion, and protease activity. Syndecan-1 and beta1 integrin signaling downstream of AG73 regulate migration, invasion, and MMP production by OSCC cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20237901     DOI: 10.1007/s13277-009-0008-x

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

Review 1.  Proteolytic modification of laminins: functional consequences.

Authors:  S Ghosh; M S Stack
Journal:  Microsc Res Tech       Date:  2000-11-01       Impact factor: 2.769

Review 2.  Tales from the crypt[ic] sites of the extracellular matrix.

Authors:  Susann Schenk; Vito Quaranta
Journal:  Trends Cell Biol       Date:  2003-07       Impact factor: 20.808

3.  Can alterations in integrin and laminin-5 expression be used as markers of malignancy?

Authors:  A K Thorup; J Reibel; M Schiødt; T C Stenersen; M H Therkildsen; W G Carter; E Dabelsteen
Journal:  APMIS       Date:  1998-12       Impact factor: 3.205

Review 4.  Functional sites in the laminin alpha chains.

Authors:  Nobuharu Suzuki; Fumiharu Yokoyama; Motoyoshi Nomizu
Journal:  Connect Tissue Res       Date:  2005       Impact factor: 3.417

5.  The effect of a reconstituted basement membrane (matrigel) on a human salivary gland myoepithelioma cell line.

Authors:  P T de Oliveira; M M Jaeger; S P Miyagi; R G Jaeger
Journal:  Virchows Arch       Date:  2001-10       Impact factor: 4.064

6.  Restricted expression and function of laminin 1-binding integrins in normal and malignant oral mucosal keratinocytes.

Authors:  K Zhang; J P Kim; D T Woodley; N S Waleh; Y Q Chen; R H Kramer
Journal:  Cell Adhes Commun       Date:  1996-09

Review 7.  The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases.

Authors:  H K Kleinman; B S Weeks; H W Schnaper; M C Kibbey; K Yamamura; D S Grant
Journal:  Vitam Horm       Date:  1993       Impact factor: 3.421

8.  Secretion of collagen I and tenascin is modulated by laminin-111 in 3D culture of human adenoid cystic carcinoma cells.

Authors:  Ruy G Jaeger; Normando Scarabotto-Neto; Nilton Azambuja; Vanessa M Freitas
Journal:  Int J Exp Pathol       Date:  2008-04       Impact factor: 1.925

9.  Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity.

Authors:  J J V Pinheiro; V M Freitas; A I S Moretti; A G Jorge; R G Jaeger
Journal:  Histopathology       Date:  2004-07       Impact factor: 5.087

10.  Laminin-alpha1-chain sequence Leu-Gln-Val-Gln-Leu-Ser-Ile-Arg (LQVQLSIR) enhances murine melanoma cell metastases.

Authors:  W H Kim; M Nomizu; S Y Song; K Tanaka; Y Kuratomi; H K Kleinman; Y Yamada
Journal:  Int J Cancer       Date:  1998-08-12       Impact factor: 7.396

View more
  8 in total

1.  Exogenous endothelin-1 induces cell migration and matrix metalloproteinase expression in U251 human glioblastoma multiforme.

Authors:  Wen-Tsong Hsieh; Wei-Lan Yeh; Ruo-Yuo Cheng; Chingju Lin; Cheng-Fang Tsai; Bor-Ren Huang; Caren Yu-Ju Wu; Hsiao-Yun Lin; Shiang-Suo Huang; Dah-Yuu Lu
Journal:  J Neurooncol       Date:  2014-04-23       Impact factor: 4.130

2.  The pivotal role of integrin β1 in metastasis of head and neck squamous cell carcinoma.

Authors:  Dongsheng Wang; Susan Müller; A R M Ruhul Amin; Donghai Huang; Ling Su; Zhongliang Hu; Mohammad Aminur Rahman; Sreenivas Nannapaneni; Lydia Koenig; Zhengjia Chen; Mourad Tighiouart; Dong M Shin; Zhuo G Chen
Journal:  Clin Cancer Res       Date:  2012-07-24       Impact factor: 12.531

3.  A robust vitronectin-derived peptide for the scalable long-term expansion and neuronal differentiation of human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs).

Authors:  Divya Varun; Gayathri Rajaram Srinivasan; Yi-Huan Tsai; Hyun-Je Kim; Joshua Cutts; Francis Petty; Ryan Merkley; Nicholas Stephanopoulos; Dasa Dolezalova; Martin Marsala; David A Brafman
Journal:  Acta Biomater       Date:  2016-10-27       Impact factor: 8.947

4.  EMMPRIN/CD147 up-regulates urokinase-type plasminogen activator: implications in oral tumor progression.

Authors:  Géraldine Lescaille; Suzanne Menashi; Bénédicte Cavelier-Balloy; Farah Khayati; Cathy Quemener; Marie Pierre Podgorniak; Benyoussef Naïmi; Fabien Calvo; Céleste Lebbe; Samia Mourah
Journal:  BMC Cancer       Date:  2012-03-23       Impact factor: 4.430

5.  Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors.

Authors:  Anna Farnedi; Silvia Rossi; Nicoletta Bertani; Mariolina Gulli; Enrico Maria Silini; Maria Teresa Mucignat; Tito Poli; Enrico Sesenna; Davide Lanfranco; Lucio Montebugnoli; Elisa Leonardi; Claudio Marchetti; Renato Cocchi; Andrea Ambrosini-Spaltro; Maria Pia Foschini; Roberto Perris
Journal:  BMC Cancer       Date:  2015-05-03       Impact factor: 4.430

6.  Laminin-111 peptide C16 regulates invadopodia activity of malignant cells through β1 integrin, Src and ERK 1/2.

Authors:  Adriane S Siqueira; Monique P Pinto; Mário C Cruz; Basilio Smuczek; Karen S P Cruz; José Alexandre M Barbuto; Daisuke Hoshino; Alissa M Weaver; Vanessa M Freitas; Ruy G Jaeger
Journal:  Oncotarget       Date:  2016-07-26

7.  The Laminin-α1 Chain-Derived Peptide, AG73, Binds to Syndecans on MDA-231 Breast Cancer Cells and Alters Filopodium Formation.

Authors:  Madhavi Puchalapalli; Liang Mu; Chevaunne Edwards; Benjamin Kaplan-Singer; Pearl Eni; Kiran Belani; David Finkelstein; Arpan Patel; Megan Sayyad; Jennifer E Koblinski
Journal:  Anal Cell Pathol (Amst)       Date:  2019-04-30       Impact factor: 2.916

Review 8.  Laminin-111-derived peptides and cancer.

Authors:  Yamato Kikkawa; Kentaro Hozumi; Fumihiko Katagiri; Motoyoshi Nomizu; Hynda K Kleinman; Jennifer E Koblinski
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.